RightFit Trial Directory

Lung Cancer clinical trials in Orange, CA

15 recruiting lung cancer studies with a site in Orange, CA.

All trials in Orange, CA · All Lung Cancer trials

RecruitingPhase 3NCT04267848

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Sponsor: National Cancer Institute (NCI)

Anaheim, CA · Antioch, CA · Arroyo Grande, CA · +1147 more sites

RecruitingPhase 2 / Phase 3NCT07100080

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Sponsor: Bristol-Myers Squibb

Irvine, CA · Orange, CA · +26 more sites

RecruitingPhase 1NCT06858813

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

Sponsor: AbbVie

Duarte, CA · Irvine, CA · Los Angeles, CA · +7 more sites

RecruitingPhase 1NCT05983432

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Sponsor: SystImmune Inc.

Beverly Hills, CA · Duarte, CA · Orange, CA · +19 more sites

RecruitingNot applicableNCT07711691

Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)

Sponsor: University of California, Irvine

Anaheim, CA · Costa Mesa, CA · Irvine, CA · +54 more sites

RecruitingPhase 3NCT06767514

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Sponsor: Summit Therapeutics

Alameda, CA · Anaheim, CA · Beverly Hills, CA · +94 more sites

RecruitingPhase 1 / Phase 2NCT04683250

Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities

Sponsor: Taiho Pharmaceutical Co., Ltd.

Orange, CA · Stanford, CA · +7 more sites

RecruitingPhase 2 / Phase 3NCT03851445

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Sponsor: SWOG Cancer Research Network

Anaheim, CA · Antioch, CA · Arroyo Grande, CA · +1226 more sites

RecruitingPhase 1 / Phase 2NCT05379985

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Sponsor: Revolution Medicines, Inc.

Orange, CA · Santa Monica, CA · +19 more sites

RecruitingPhase 2NCT04701476

TATE and Pembrolizumab (MK3475) in mCRC and NSCLC

Sponsor: Teclison Ltd.

Orange, CA

RecruitingPhase 1 / Phase 2NCT06244771

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Sponsor: Frontier Medicines Corporation

La Jolla, CA · Orange, CA · San Francisco, CA · +12 more sites

RecruitingPhase 2NCT07447050

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

Sponsor: University of California, Irvine

Orange, CA

RecruitingPhase not listedNCT06221800

Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects

Sponsor: University of California, Irvine

Orange, CA

RecruitingPhase 2NCT04079179

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

Sponsor: Carl Allen

Orange, CA · San Francisco, CA · +10 more sites

RecruitingPhase 1 / Phase 2NCT05394831

A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC

Sponsor: J Ints Bio

Orange, CA

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.